Review of ACC 2020 Late-Breaking Trials in Interventional Cardiology

Brian C Case; Charan Yerasi; Brian J Forrestal; Chava Chezar-Azerrad; Evan Shlofmitz; Jaffar M Khan; Nauman Khalid; Jason P Wermers; Ron Waksman

doi:10.1016/j.carrev.2020.04.027

Review of ACC 2020 Late-Breaking Trials in Interventional Cardiology

Cardiovasc Revasc Med. 2020 Jul;21(7):905-911. doi: 10.1016/j.carrev.2020.04.027. Epub 2020 Apr 25.

Authors

Brian C Case¹, Charan Yerasi¹, Brian J Forrestal¹, Chava Chezar-Azerrad¹, Evan Shlofmitz¹, Jaffar M Khan¹, Nauman Khalid¹, Jason P Wermers¹, Ron Waksman²

Affiliations

¹ Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America.
² Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America. Electronic address: ron.waksman@medstar.net.

No abstract available

Keywords: Anticoagulation; Antiplatelet therapy; Percutaneous coronary intervention; Peripheral artery disease; Renal denervation; Transcatheter aortic valve replacement.

Publication types

Review

MeSH terms

Cardiology*
Cardiovascular Diseases / diagnosis
Cardiovascular Diseases / mortality
Cardiovascular Diseases / therapy*
Clinical Trials as Topic*
Congresses as Topic
Humans
Treatment Outcome